StockData
GSK plc logo

GSK plc (GSK) stock

GSKNYSEPharmaceutical PreparationsAlso trades as GLAXF
Financials through fiscal 2025, year ended Dec 31, 2025Score 9/30
$49.24−1.17 (-2.32%)

Close on Nov 17, 2026Market cap $106.25BP/E 13.4Yield –

GSK enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

GSK's enterprise value was $122.75B on Nov 11, 2026, against $115.71B a year earlier. Over the last 5 years it ranged from $87.71B to $147.11B, with a median of $103.36B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$122.75B+3.7%
2025Dec 31, 2025$118.41B+35.0%
2024Dec 31, 2024$87.71B-9.6%
2023Dec 29, 2023$97.04B-5.6%
2022Dec 30, 2022$102.82B-29.3%
2021Dec 31, 2021$145.50B+7.6%
2020Dec 31, 2020$135.27B-6.0%
2019Dec 31, 2019$143.85B+26.1%
2018Dec 31, 2018$114.04B+4.3%
2017Dec 29, 2017$109.38B+28.5%
2016Dec 30, 2016$85.12B–

More GSK figures

See a number that looks wrong?